Malaysian glove manufacturer Adventa Health has debutedtheir Finessis surgical glove series.No accelerators or binding chemicals are added in the manufacturing process as the glove film is casted as solid film from true solutions without any crosslinking agent required.
The process is achieved through molecular layering technology. Each pair represents a block of co-polymers built in multiple,uniform, molecular layers with virtually no pinholes.
“Strong walls of molecular layers offer total protection barrier, prohibits any potential fluids or microorganism from penetrating through the glove film”, says Adventa Health marketing executive, Mohd Naim.
Latex-free, accelerator-free, and with zero-added chemicals, the Finessis series eliminates all risks of irritant contact dermatitis, latex allergies, and chemical-related allergies.
Adventa Health offers a series of three designs with their biggest product, Finessis AEGIS, being aspecially-developedsurgical glove for trauma and high-risk doctors. The gloves are manufactured with a unique middle layer of disinfecting liquid. In the event of percutaneous blood exposure or a needlestick injury and the glove is breached, the designed mechanism of the glove will release the disinfecting liquid and sterilise the needle or sharp object. The disinfectant is not in contact with the wearer’s skin in normal glove wear, therefore mitigating over-sensitisation of chemical compounds on the skin.
The efficacy of the Finessis Aegis glove has been demonstrated during in vitro tests conducted on enveloped viruses, including the HIV virus. The studies have shown that the glove reduces the number of HIV virus transmitted in the event of puncture by 96% when compared to double gloves, and as much as 98% when compared to a puncture with no glove protection.